310 related articles for article (PubMed ID: 38800358)
1. Melasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy.
Philipp-Dormston WG
Clin Cosmet Investig Dermatol; 2024; 17():1203-1216. PubMed ID: 38800358
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid in melasma: A focused review on drug administration routes.
Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Topical Tranexamic Acid Alone or in Combination with Either Fractional Carbon Dioxide Laser or Microneedling for the Treatment of Melasma.
Mamdouh Kamal Dawaud S; Hegab DS; Mohamed El Maghraby G; Ahmad El-Ashmawy A
Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557109
[TBL] [Abstract][Full Text] [Related]
4. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
5. Melasma Treatment: An Evidence-Based Review.
McKesey J; Tovar-Garza A; Pandya AG
Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
[TBL] [Abstract][Full Text] [Related]
6. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
Sofen B; Prado G; Emer J
Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
[TBL] [Abstract][Full Text] [Related]
7. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
[TBL] [Abstract][Full Text] [Related]
8. Melasma: an Up-to-Date Comprehensive Review.
Ogbechie-Godec OA; Elbuluk N
Dermatol Ther (Heidelb); 2017 Sep; 7(3):305-318. PubMed ID: 28726212
[TBL] [Abstract][Full Text] [Related]
9. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
10. Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.
Piętowska Z; Nowicka D; Szepietowski JC
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231404
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
[TBL] [Abstract][Full Text] [Related]
12. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
13. Melasma in Latin America: options for therapy and treatment algorithm.
Cestari T; Arellano I; Hexsel D; Ortonne JP;
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
[TBL] [Abstract][Full Text] [Related]
14. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
[TBL] [Abstract][Full Text] [Related]
15. Definition of refractory melasma and its treatment: a review.
Yao H; Shen S; Gao X; Feng J; Song X; Xiang W
Lasers Med Sci; 2024 Apr; 39(1):118. PubMed ID: 38679674
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
Feng X; Su H; Xie J
J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of oral tranexamic acid as a novel treatment for melasma with a high benefit-risk ratio.
Simpson J; Peng L; Ting W
J Cosmet Dermatol; 2022 Nov; 21(11):6393-6399. PubMed ID: 35972476
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of energy-based devices combination therapy for melasma.
Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
Dermatol Ther; 2021 May; 34(3):e14927. PubMed ID: 33665885
[TBL] [Abstract][Full Text] [Related]
19. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
Bailey AJM; Li HO; Tan MG; Cheng W; Dover JS
J Am Acad Dermatol; 2022 Apr; 86(4):797-810. PubMed ID: 33857549
[TBL] [Abstract][Full Text] [Related]
20. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
